Rupendra Shrestha

13PUBLICATIONS
10CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 10, 2026
Optimized polyethylene glycol precipitation yields high-purity, biologically active mouse liver tissue exosomes.

|Jan 07, 2026
Exploring Fecal Microbiota Transplantation: Potential Benefits, Associated Risks, and Challenges in Cancer Treatment.

Aswathi Ramesh, Rajasekaran Subbarayan, Rupendra Shrestha

|Nov 28, 2025
Infectious Triggers and Immune Dynamics in Guillain-Barré Syndrome: Revisiting Campylobacter jejuni and the Silent Role of Haemophilus influenzae.

Aswathi Ramesh, Rajasekaran Subbarayan, Dhasarathdev Srinivasan

|Nov 26, 2025
Liposome-Encapsulated Melatonin Mitigates Amoxicillin-Induced Neurotoxicity in a Zebrafish.

Ranjith Balakrishnan, Rajasekaran Subbarayan, Rupendra Shrestha

|Sep 02, 2025
Epithelial-Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications.

Dhasarathdev Srinivasan, Ranjith Balakrishnan, Ankush Chauhan

|Jul 28, 2025
Intersection of COVID-19 and Alzheimer's Disease: Genetic Insights and Neuropathological Consequences.

Ranjith Balakrishnan, Rajasekaran Subbarayan, Rupendra Shrestha

Pageof 3

Frequent Collaborators

9 joint publications

Rajasekaran Subbarayan

2 joint publications

Ankush Chauhan

1 joint publications

Dah-Ching Ding

1 joint publications

Rong-Kung Tsai